Education
About Us
Working with TipRanks
Follow Us
Quinsam Capital Corporation (TSE:QCA)
:QCA
Top Page
Quinsam Capital
(QCA)
Select Model
Select Model
Rating:46Neutral
Price Target:―
Quinsam Capital's financial performance is constrained by consistent negative revenue and cash flow difficulties, despite having a strong equity position. Technical indicators suggest caution due to potential overbought conditions, and valuation metrics are unfavorable with a negative P/E ratio.
Positive Factors
Investment in High-Potential Sectors
Investing in high-potential sectors like technology and healthcare can drive long-term growth, positioning the company to capitalize on emerging market trends and innovations.
Diversified Revenue Model
A diversified revenue model reduces dependency on a single income source, enhancing resilience against sector-specific downturns and allowing for steady cash flow generation.
Strong Equity Position
A strong equity position with no debt provides financial stability and flexibility, allowing the company to withstand economic downturns and invest in growth opportunities.
Negative Factors
Declining Gross Profit Margins
Declining margins suggest inefficiencies or increased costs, which can erode profitability and reduce the company's competitive edge over the long term.
Negative Cash Flow
Negative cash flow indicates challenges in maintaining liquidity and funding operations, potentially limiting the company's ability to invest in growth and meet financial obligations.
Negative Revenue and Profitability
Persistent negative revenue and profitability hinder the company's ability to generate sustainable earnings, posing a risk to long-term financial health and investor confidence.
Quinsam Capital (QCA) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$4.49M
Dividend YieldN/A
Average Volume (3M)20.38K
Price to Earnings (P/E)―
Beta (1Y)-0.16
Revenue Growth26.42%
EPS Growth-1217.14%
CountryCA
EmployeesN/A
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)<0.01
Shares Outstanding89,849,106
10 Day Avg. Volume17,075
30 Day Avg. Volume20,383
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.46
Price to Sales (P/S)-2.21
P/FCF Ratio-8.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Quinsam Capital Business Overview & Revenue Model
Company DescriptionQuinsam Capital Corporation (QCA) is a Canada-based investment firm operating primarily in the financial services sector. The company focuses on providing growth capital to small-cap companies across various industries, including technology, healthcare, and resource sectors. Quinsam Capital engages in both private and public investments, leveraging its expertise to identify undervalued opportunities that have the potential for significant returns.
How the Company Makes MoneyQuinsam Capital makes money through a diversified revenue model primarily centered around investment income. The company generates revenue by deploying capital into public and private equity investments and realizing gains when these investments appreciate in value. Key revenue streams include dividends, interest income from debt investments, and capital gains from the sale of equity positions. Quinsam Capital's earnings are influenced by its ability to identify profitable investment opportunities and effectively manage its investment portfolio. Partnerships with emerging growth companies and strategic investments in high-potential sectors also contribute to its financial performance.
Quinsam Capital Earnings Call Summary
Earnings Call Date:Dec 01, 2025
(Q3-2025)
| Next Earnings Date:May 04, 2026
Earnings Call Sentiment Neutral
The earnings call presents a cautiously optimistic outlook for Q4, with significant potential gains from private investments going public and successful developments in medical trials. However, challenges such as the Newlox Gold cease trade and complications with a potential transaction introduce some uncertainty.Q3-2025 Updates
Positive Updates
Private Investments Going Public
Two private investments, Peninsula (now Renterz) and Electro Metals, are looking to go public in Q4. Peninsula is a U.S. single-family rental business trying to raise funds at $1.90 per share, and Electro Metals is a traditional Canadian mining company focused on copper and gold, awaiting final listing approval.
Successful CBD Treatment Trials
A-Synaptic, a company developing CBD treatment for epilepsy, has been approved by the FDA for a clinical trial at Boston's Children's Hospital. Additionally, a $3 million grant from the Michael J. Fox Foundation is funding a trial for using the same treatment for Parkinson's.
Positive Outlook for Q4
Expectations for a profitable Q4 are supported by potential gains from private investments going public and improvement in the valuation of companies like Newlox Gold, which is expected to resume trading at $0.05-$0.06 per share.
Negative Updates
Newlox Gold Cease Trade
Newlox Gold is currently under a cease trade due to late financials, leading to a conservative valuation of 0 in Q3. However, it was trading around $0.05-$0.06 before the halt.
Complications with Potential Transaction
A promising transaction with an American-based company faces income tax complications for main shareholders, which are delaying the deal.
Company Guidance
During the Quinsam third-quarter conference call, Roger Dent highlighted key developments expected in Q4, including two private investments set to list: Peninsula, a U.S. single-family rental business aiming to raise funds at $1.90 under the name Renterz, and Electro Metals, a copper and gold mining company awaiting final exchange approval. These listings could enhance the net asset value (NAV) from $0.06 to $0.08, with further potential growth. He also mentioned A-Synaptic, which is developing a CBD treatment for epilepsy and Parkinson's, backed by a $3 million grant from the Michael J. Fox Foundation. Additionally, Newlox Gold, currently under a cease trade, is expected to resume trading at approximately $0.05-$0.06. Dent expressed optimism for a profitable Q4 despite market volatility, with potential transactions involving an American-based cash flow-positive company under consideration, contingent on resolving tax complications.Quinsam Capital Financial Statement Overview
Summary
Quinsam Capital faces financial challenges, with negative revenue and profitability impacting its income statement. Despite a strong balance sheet featuring no debt and high equity, cash flow remains negative, reflecting difficulties in generating positive free cash flow.Income Statement
The income statement reflects a challenging financial period for Quinsam Capital, with consistent negative revenue and declining gross profit margins. The net profit margin remains negative, indicating persistent losses. Despite a reduction in losses from the previous year, the company's revenue growth rate is negative, highlighting ongoing challenges in generating positive revenue.30
Negative
Balance Sheet
Quinsam Capital's balance sheet shows a strong equity position with zero total debt, resulting in a favorable debt-to-equity ratio. However, the return on equity (ROE) is negative due to net losses, affecting overall profitability. The equity ratio is high, indicating a stable financial structure with significant shareholder equity.60
Neutral
Cash Flow
The cash flow statement reveals negative free cash flow in the trailing twelve months, alongside a negative operating cash flow to net income ratio. The company has faced challenges in generating positive operating cash flow, though it managed to maintain some liquidity through cash reserves. The free cash flow growth rate is negative, highlighting cash flow difficulties.40
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -1.49M | -1.90M | -7.39M | -1.54M | -1.20M | 3.10M |
| Gross Profit | -1.71M | -2.13M | -7.63M | -1.78M | -1.42M | 2.73M |
| EBITDA | -3.12M | -2.98M | -2.92M | -16.18M | -2.11M | 2.16M |
| Net Income | -3.12M | -3.02M | -2.02M | -15.52M | -2.48M | 2.44M |
Balance Sheet | ||||||
| Total Assets | 9.17M | 9.26M | 12.40M | 14.85M | 31.93M | 34.83M |
| Cash, Cash Equivalents and Short-Term Investments | 384.13K | 313.23K | 1.18M | 855.37K | 58.38K | 32.87M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 86.28K | 0.00 |
| Total Liabilities | 129.91K | 125.69K | 158.35K | 279.80K | 1.18M | 659.45K |
| Stockholders Equity | 9.04M | 9.13M | 12.24M | 14.57M | 30.75M | 34.17M |
Cash Flow | ||||||
| Free Cash Flow | -801.95K | -472.08K | 326.98K | 1.51M | 347.54K | 1.81M |
| Operating Cash Flow | -801.95K | -472.08K | 326.98K | 1.51M | 347.54K | 1.81M |
| Investing Cash Flow | 228.51K | -211.95K | 324.31K | 2.25M | -86.86K | 0.00 |
| Financing Cash Flow | -191.29K | -181.91K | -327.48K | -717.54K | -1.40M | -1.37M |
Quinsam Capital Technical Analysis
Negative
0.05
Price Trends
0.05
Negative
0.05
Negative
0.05
Negative
Market Momentum
>-0.01
Negative
45.59
Neutral
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:QCA, the sentiment is Negative. The current price of 0.05 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 45.59 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:QCA.
Quinsam Capital Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | C$6.02M | 3.09 | 42.23% | 7.92% | -54.61% | 273.14% | |
46 Neutral | C$4.49M | -1.45 | -37.19% | ― | 26.42% | -1217.14% | |
46 Neutral | C$5.37M | -0.26 | -55.73% | ― | 53.55% | -289.42% | |
43 Neutral | C$13.16M | ― | -113.97% | ― | -19.49% | -25.00% | |
41 Neutral | C$883.17K | -0.07 | ― | ― | ― | ― | |
35 Underperform | C$4.67M | -1.74 | -226.11% | ― | 19.82% | -51.61% |
* Financial Sector Average
TSE:QCA
Quinsam Capital
0.05
0.00
0.00%
TSE:BLGV
Belgravia Capital International Inc
0.04
0.02
100.00%
TSE:IDK
ThreeD Capital
0.07
-0.11
-61.11%
TSE:PDV
Prime Dividend Cl A
11.01
3.18
40.61%
TSE:MONT
TIMIA Capital
0.01
-0.05
-83.33%
TSE:LBI
Lions Bay Capital
0.34
0.22
183.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.